Verona Pharma started a Phase 2b dose-ranging study testing the safety and efficacy of nebulized ensifentrine (RPL554) as an…
Santiago Gisler
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Santiago Gisler
Video telehealth rehabilitation reduced the rates that patients with chronic obstructive pulmonary disease (COPD) had to be readmitted within 30…
The Loop wristband device, designed to remotely monitor the condition of patients with chronic diseases such as chronic obstructive…
New Tool Identifies Support Needs of COPD Patients, Helping to Make Care More Personal and Holistic
A new tool identifying broad areas of need by patients receiving palliative or end-of-life care may improve personalized care for…
Differences in DNA may explain lung health and the risk of chronic obstructive pulmonary disease (COPD) in both smokers and…
Patients with chronic obstructive pulmonary disease (COPD) are unaware of their increased lung cancer risk compared with the general…
Statins Linked to Better Outcomes and Improved Lung Function in COPD Patients, Meta-analysis Finds
Statins, commonly used to lower blood cholesterol levels, can help chronic obstructive pulmonary disease (COPD) patients by preventing or treating…
People with chronic obstructive pulmonary disease (COPD) have an increased risk of severe illness, hospitalization, and death if they…
Data from a three-day Phase 2 clinical trial offered positive results for nebulized ensifentrine (RPL544) as an add-on treatment for chronic obstructive pulmonary disease…
Cognitive behavioral therapy (CBT) intervention can alleviate anxiety in people with chronic obstructive pulmonary disease (COPD), and reduce long-term hospital…